Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 168

1.

Cardiovascular effects of mixed amphetamine salts extended release in the treatment of school-aged children with attention-deficit/hyperactivity disorder.

Donner R, Michaels MA, Ambrosini PJ.

Biol Psychiatry. 2007 Mar 1;61(5):706-12. Epub 2006 Aug 8.

PMID:
16899230
[PubMed - indexed for MEDLINE]
2.

An open-label study of the tolerability of mixed amphetamine salts in adults with attention-deficit/hyperactivity disorder and treated primary essential hypertension.

Wilens TE, Zusman RM, Hammerness PG, Podolski A, Whitley J, Spencer TJ, Gignac M, Biederman J.

J Clin Psychiatry. 2006 May;67(5):696-702.

PMID:
16841618
[PubMed - indexed for MEDLINE]
3.

Short- and long-term cardiovascular effects of mixed amphetamine salts extended release in children.

Findling RL, Biederman J, Wilens TE, Spencer TJ, McGough JJ, Lopez FA, Tulloch SJ; SLI381.301 and .302 Study Groups.

J Pediatr. 2005 Sep;147(3):348-54.

PMID:
16182674
[PubMed - indexed for MEDLINE]
4.

Long-term cardiovascular effects of mixed amphetamine salts extended release in adults with ADHD.

Weisler RH, Biederman J, Spencer TJ, Wilens TE.

CNS Spectr. 2005 Dec;10(12 Suppl 20):35-43.

PMID:
16344839
[PubMed - indexed for MEDLINE]
5.

A community assessment, open-label study of the safety, tolerability, and effectiveness of mixed amphetamine salts extended release in school-age children with ADHD.

Ambrosini PJ, Sallee FR, Lopez FA, Shi L, Michaels MA; LADD.CAT Study Group.

Curr Med Res Opin. 2006 Feb;22(2):427-40.

PMID:
16466615
[PubMed - indexed for MEDLINE]
8.

Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.

Quintana H, Cherlin EA, Duesenberg DA, Bangs ME, Ramsey JL, Feldman PD, Allen AJ, Kelsey DK.

Clin Ther. 2007 Jun;29(6):1168-77.

PMID:
17692731
[PubMed - indexed for MEDLINE]
9.

Bioavailability of triple-bead mixed amphetamine salts compared with a dose-augmentation strategy of mixed amphetamine salts extended release plus mixed amphetamine salts immediate release.

Ermer JC, Shojaei A, Pennick M, Anderson CS, Silverberg A, Youcha SH.

Curr Med Res Opin. 2007 May;23(5):1067-75.

PMID:
17519073
[PubMed - indexed for MEDLINE]
10.

Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents.

Garnock-Jones KP, Keating GM.

Paediatr Drugs. 2009;11(3):203-26. doi: 10.2165/00148581-200911030-00005. Review.

PMID:
19445548
[PubMed - indexed for MEDLINE]
11.

Health care costs of adults treated for attention-deficit/hyperactivity disorder who received alternative drug therapies.

Wu EQ, Birnbaum HG, Zhang HF, Ivanova JI, Yang E, Mallet D.

J Manag Care Pharm. 2007 Sep;13(7):561-9.

PMID:
17874862
[PubMed - indexed for MEDLINE]
Free Article
13.
14.

Long-term effects of extended-release mixed amphetamine salts treatment of attention- deficit/hyperactivity disorder on growth.

Faraone SV, Biederman J, Monuteaux M, Spencer T.

J Child Adolesc Psychopharmacol. 2005 Apr;15(2):191-202.

PMID:
15910204
[PubMed - indexed for MEDLINE]
15.

An interim analysis of the Quality of Life, Effectiveness, Safety, and Tolerability (QU.E.S.T.) evaluation of mixed amphetamine salts extended release in adults with ADHD.

Goodman DW, Ginsberg L, Weisler RH, Cutler AJ, Hodgkins P.

CNS Spectr. 2005 Dec;10(12 Suppl 20):26-34.

PMID:
16344838
[PubMed - indexed for MEDLINE]
16.

Long-term tolerability and effectiveness of once-daily mixed amphetamine salts (Adderall XR) in children with ADHD.

McGough JJ, Biederman J, Wigal SB, Lopez FA, McCracken JT, Spencer T, Zhang Y, Tulloch SJ.

J Am Acad Child Adolesc Psychiatry. 2005 Jun;44(6):530-8.

PMID:
15908835
[PubMed - indexed for MEDLINE]
17.

Cardiovascular effects of longer-term, high-dose OROS methylphenidate in adolescents with attention deficit hyperactivity disorder.

Hammerness P, Wilens T, Mick E, Spencer T, Doyle R, McCreary M, Becker J, Biederman J.

J Pediatr. 2009 Jul;155(1):84-9, 89.e1. doi: 10.1016/j.jpeds.2009.02.008. Epub 2009 Apr 25.

PMID:
19394037
[PubMed - indexed for MEDLINE]
18.
19.

Safety, efficacy and extended duration of action of mixed amphetamine salts extended-release capsules for the treatment of ADHD.

Weisler RH.

Expert Opin Pharmacother. 2005 Jun;6(6):1003-18. Review.

PMID:
15952928
[PubMed - indexed for MEDLINE]
20.

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk